enGene Holdings ENGN 深 滬
已收盤 01-02 16:00:00 美东时间
8.85
-0.180
-1.99%
華盛通- 最 高9.10
- 今 開9.09
- 成交量 12.74万股
- 最 低 8.4422
- 昨 收 9.03
- 總市值 4.53亿
- 52周最高 11.14
- 市盈率 靜 --
- 換手率 0.25%
- 52周最低 2.65
- 委 比 -91.13%
- 總股本 5119.18万
- 歷史最高 43.00
- 量 比 0.39
- 振 幅 7.28%
- 歷史最低 2.65
- 每 手 1
- 風險率 1.88%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多enGene Holdings GAAP EPS of $2.29
enGene Holdings press release (ENGN): FY GAAP EPS of $2.29. Full Year Financial Results ended October 31, 2025Total operating expenses were $123.2 million for the full year ended October 31, 2025, com...
2025-12-23 05:05
enGene Holdings Q4 EPS $(0.73) Misses $(0.57) Estimate
enGene Holdings (NASDAQ:ENGN) reported quarterly losses of $(0.73) per share which missed the analyst consensus estimate of $(0.57) by 28.3 percent. This is a 114.71 percent decrease over losses of $(0.34) per share from
2025-12-23 05:04
enGene Holdings Says FDA Selects Detalimogene Voraplasmid To Participate In Chemistry, Manufacturing, And Controls Development And Readiness Pilot Program
enGene one of nine companies awarded CDRP per yearProgram aims to support CMC development of products with expedited clinical development timeframes and provide patients with earlier access to these productsDetalimogene
2025-12-02 20:37
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers enGene Holdings (NASDAQ:ENGN) stock moved upwards by 3.5% to $7.12 dur...
2025-11-19 05:06
美股大行评级 | 富国银行上调AMD目标价升至345美元；花旗上调礼来目标价升至1500美元；巴克莱上调腾讯音乐目标价升至28美元
今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从12美元升至15美元；Canaccord Genuity：维持Viking Therapeutics"买入"评级，目标价从106美元升至107美元
2025-11-13 09:58
enGene Holdings Announces Public Offering of Common Shares
An announcement from enGene Holdings ( ($ENGN) ) is now available. enGene Holdi...
2025-11-13 06:19
UBS Maintains Neutral on enGene Holdings, Raises Price Target to $10
UBS analyst Colin Bristow maintains enGene Holdings (NASDAQ:ENGN) with a Neutral and raises the price target from $4 to $10.
2025-11-12 22:27
美股牛股 | ENGN隔夜大涨近47%！膀胱癌基因疗法试验数据表现积极；二手奢侈品在线交易平台REAL涨超38%
ENGN隔夜大涨近47%！膀胱癌基因疗法试验数据表现积极；二手奢侈品在线交易平台REAL涨超38%，Q3业绩超预期及上调财年销售指引>>
2025-11-12 18:55
Here’s Why enGene Holdings Stock Is Soaring Today
enGene Holdings ($ENGN) stock is soaring on Tuesday after releasing promising p...
2025-11-12 03:06
enGene’s Detalimogene Shows Promising Results in Bladder Cancer Trial
enGene Holdings ( ($ENGN) ) has issued an announcement. enGene Holdings Inc. ha...
2025-11-11 21:09
